Lenercept tumor necrosis factor fusion protein data

Roche halted its 247-patient Phase II trial of Lenercept versus methotrexate after Lenercept failed to

Read the full 157 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE